MEI Pharma raised $100 M in a Post-IPO round on 2025-07-21.

According to media reports, MEI Pharma raised $100 M in a Post-IPO round on 2025-07-21.Following this round, MEI Pharma's total funding reached $100 M.
MEI Pharma, Inc.(Nasdaq: MEIP), ABD'nin California eyaletinin San Diego şehrinde merkezi bulunan, kanserin ilaç direnç mekanizmalarıyla mücadele etmeye odaklanan yenilikçi tedaviler geliştiren, klinik aşamada bir ilaç şirketidir. Amaç, standart tedavilerle kombinasyon halinde hasta sonuçlarını iyileştirmektir.

This content is AI-generated.Please verify before use.

Disclaimer: The Crypto Calendar is for informational purposes only and doesn’t reflect Gate.com’s views or serve as financial advice.

5
0
0
Share

Comment

Fundraising History
RoundAmountValuationTimeInvestor(s)
Post-IPO$100 M--2025-07-21--
Key Milestones
  • 2025-07-22
    MEI Pharma, finansmanda 100 milyon dolarlık özel yerleşim tamamladı
  • GT
    -1.78%
  • BTC
    -2.73%
  • ETH
    -3.72%
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)